BYSANTI

NDC 43068-913, MILSAPERIDONE, kit, from Vanda Pharmaceuticals Inc..

Product NDC: 43068-913
Status: Listed
Labeler: Vanda Pharmaceuticals Inc.
Dosage form: KIT
Route: ORAL
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: NDA
Application: NDA220358
DEA schedule: None

Request

curl https://api.healthcare.dev/v1/drugs/ndc/43068-913 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDC	NDC-11	Package
43068-913-12	43068091312	4 CARTON in 1 BLISTER PACK (43068-913-12) / 1 KIT in 1 CARTON

Linked data

RxNorm, label and prices

RxNorm concepts

2746021{6 (milsaperidone 1 MG Oral Tablet [Bysanti]) / 2 (milsaperidone 2 MG Oral Tablet [Bysanti]) / 2 (milsaperidone 6 MG Oral Tablet [Bysanti]) / 2 (milsaperidone 8 MG Oral Tablet [Bysanti]) } Pack [Bysanti Titration Pack B] (BPCK)

Related lookups

FDA label sections
GET /v1/drugs/labels/254a1c01-4a4c-4bdd-85d6-1f23f2e4e6f8

Use it

Look up 43068-913 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/ndc/43068-913 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up NDC 43068-913. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Get a free key NDC docs Connect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.